These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 22056140)

  • 1. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.
    Lonardo E; Hermann PC; Mueller MT; Huber S; Balic A; Miranda-Lorenzo I; Zagorac S; Alcala S; Rodriguez-Arabaolaza I; Ramirez JC; Torres-Ruíz R; Garcia E; Hidalgo M; Cebrián DÁ; Heuchel R; Löhr M; Berger F; Bartenstein P; Aicher A; Heeschen C
    Cell Stem Cell; 2011 Nov; 9(5):433-46. PubMed ID: 22056140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
    Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
    Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness.
    Perkhofer L; Walter K; Costa IG; Carrasco MC; Eiseler T; Hafner S; Genze F; Zenke M; Bergmann W; Illing A; Hohwieler M; Köhntop R; Lin Q; Holzmann KH; Seufferlein T; Wagner M; Liebau S; Hermann PC; Kleger A; Müller M
    Stem Cell Res; 2016 Sep; 17(2):367-378. PubMed ID: 27632063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
    Cioffi M; Trabulo SM; Sanchez-Ripoll Y; Miranda-Lorenzo I; Lonardo E; Dorado J; Reis Vieira C; Ramirez JC; Hidalgo M; Aicher A; Hahn S; Sainz B; Heeschen C
    Gut; 2015 Dec; 64(12):1936-48. PubMed ID: 25887381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness.
    Lonardo E; Frias-Aldeguer J; Hermann PC; Heeschen C
    Cell Cycle; 2012 Apr; 11(7):1282-90. PubMed ID: 22421149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion
    Li K; Zhang Z; Mei Y; Yang Q; Qiao S; Ni C; Yao Y; Li X; Li M; Wei D; Fu W; Guo X; Huang X; Yang H
    Theranostics; 2021; 11(7):3196-3212. PubMed ID: 33537082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.
    Mueller MT; Hermann PC; Witthauer J; Rubio-Viqueira B; Leicht SF; Huber S; Ellwart JW; Mustafa M; Bartenstein P; D'Haese JG; Schoenberg MH; Berger F; Jauch KW; Hidalgo M; Heeschen C
    Gastroenterology; 2009 Sep; 137(3):1102-13. PubMed ID: 19501590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activin/Nodal signalling in stem cells.
    Pauklin S; Vallier L
    Development; 2015 Feb; 142(4):607-19. PubMed ID: 25670788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation.
    Okada M; Shibuya K; Sato A; Seino S; Suzuki S; Seino M; Kitanaka C
    Oncotarget; 2014 Jul; 5(13):5100-12. PubMed ID: 24947996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pig epiblast stem cells depend on activin/nodal signaling for pluripotency and self-renewal.
    Alberio R; Croxall N; Allegrucci C
    Stem Cells Dev; 2010 Oct; 19(10):1627-36. PubMed ID: 20210627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
    Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
    World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The low chamber pancreatic cancer cells had stem-like characteristics in modified transwell system: is it a novel method to identify and enrich cancer stem-like cells?
    Wang D; Zhu H; Liu Y; Liu Q; Xie X; Zhou Y; Zhang L; Zhu Y; Zhang Z; Su Z
    Biomed Res Int; 2014; 2014():760303. PubMed ID: 24689055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graded Nodal/Activin signaling titrates conversion of quantitative phospho-Smad2 levels into qualitative embryonic stem cell fate decisions.
    Lee KL; Lim SK; Orlov YL; Yit le Y; Yang H; Ang LT; Poellinger L; Lim B
    PLoS Genet; 2011 Jun; 7(6):e1002130. PubMed ID: 21731500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cancerous stem cells during embryonic stem cell differentiation.
    Fujimori H; Shikanai M; Teraoka H; Masutani M; Yoshioka K
    J Biol Chem; 2012 Oct; 287(44):36777-91. PubMed ID: 22961983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.
    Li D; Su D; Xue L; Liu Y; Pang W
    Int J Clin Exp Pathol; 2015; 8(9):11218-23. PubMed ID: 26617845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.
    Shi CJ; Gao J; Wang M; Wang X; Tian R; Zhu F; Shen M; Qin RY
    World J Gastroenterol; 2011 Jun; 17(24):2965-71. PubMed ID: 21734809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells.
    Zhang GN; Liang Y; Zhou LJ; Chen SP; Chen G; Zhang TP; Kang T; Zhao YP
    Cancer Lett; 2011 Dec; 313(2):137-44. PubMed ID: 22030254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.
    Chai X; Chu H; Yang X; Meng Y; Shi P; Gou S
    Sci Rep; 2015 Sep; 5():14404. PubMed ID: 26391180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.